The Company is delighted to announce the launching of its premium CBD product lines in the coming weeks. The launch includes the CBD cosmetics line and the CBD coffee line in pharmacies, convenience stores and hotels across South Africa. The products are branded under the trademarks: DrAnnaRx™ and Medspresso™ respectively.

List of products this month: Dr. AnnaRx exclusive line of CBD infused beauty and health products: Day Cream, Night Cream, Serum, Shampoo, Conditioner, UV Sun Protector. Medspresso™, an exclusive line of CBD infused espresso and coffee in capsule format. The flavors offered are Tanzanian Peaberry, light, medium and dark roast, and decaf coffee. The Company has retained the services of a law firm to work on the cancellation of 19,844,398 shares of WUHN Common Stock held by Fame Good International Limited previously issued under past management. Wuhan strongly believes that the shares were issued inappropriately and will be canceled and returned to the treasury. After cancellation, the outstanding shares count would be 22.4 million shares. A 47% reduction of the current outstanding shares counts of 42.2 million shares. Another positive step in enhancing shareholder value.

Located in the Kingdom of Lesotho in Southern Africa, Tsime has the license for the cultivation of 3 hectares of medicinal grade cannabis on a farm with a land area covering 32 hectares or 80 acres. The acquisition is extremely strategic for Wuhan. Having its own cultivation, extraction and processing medicinal cannabis operation, is key to driving research and the manufacturing of CBD by-products.